Novanta (NASDAQ:NOVT) Stock Gets Downgrade from Wall Street Zen

Novanta (NASDAQ:NOVT – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Sunday, Wall Street Zen reports.

Other equities research analysts have also recently issued research reports about the stock. Robert W. Baird lowered their target price on shares of Novanta from $194.00 to $175.00 and set an “outperform” rating on the stock in a report on Thursday, November 12th. Zacks Research lowered Novanta from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 6th. Finally, Weiss Ratings lowered Novanta from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, November 10th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $175.00.

Get Our Latest Stock Analysis on Novanta

Novanta Price Performance

Shares of NASDAQ:NOVT opened at $114.40 on Friday. The firm has a market capitalization of $4.33 billion, a PE ratio of 87.33, a P/E/G ratio of 2.55 and a beta of 1.71. The company has a quick ratio of 3.79, a current ratio of 1.18 and a debt-to-equity ratio of 0.48. The company has a 50-day moving average price of $139.61 and a two-hundred day moving average price of $142.12. Novanta has a twelve month low of $98.27 and a twelve month high of $176.38.

Novanta (NASDAQ:NOVT – Get Free Report) last posted its quarterly earnings results on Monday, November 9th. The technology company reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.08. The company had revenue of $305.01 million for the quarter, compared to analyst estimates of $301.02 million. Novanta had a net margin of 4.89% and a return on equity of 10.23%. The company’s quarterly revenue was up 23.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.87 earnings per share. Equities analysts forecast that Novanta will post 3.68 EPS for the current year.

Institutional Investors Weigh In On Novanta

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Pinnacle Wealth Planning Services Inc. boosted its position in shares of Novanta by 29.5% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 303 shares of the technology company’s stock valued at $43,000 after acquiring an additional 69 shares during the period. Envestnet Portfolio Solutions Inc. grew its stake in Novanta by 3.8% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 1,914 shares of the technology company’s stock valued at $311,000 after acquiring an additional 70 shares in the last quarter. Hantz Financial Services Inc. grew its stake in Novanta by 6.5% during the third quarter. Hantz Financial Services Inc. now owns 1,274 shares of the technology company’s stock valued at $181,000 after acquiring an additional 78 shares in the last quarter. Fifth Third Bancorp increased its holdings in Novanta by 12.8% during the 1st quarter. Fifth Third Bancorp now owns 778 shares of the technology company’s stock worth $92,000 after acquiring an additional 88 shares during the period. Finally, State of Michigan Retirement System increased its holdings in Novanta by 1.2% during the 1st quarter. State of Michigan Retirement System now owns 8,600 shares of the technology company’s stock worth $1,016,000 after acquiring an additional 100 shares during the period. 98.35% of the stock is currently owned by institutional investors.

Novanta Company Profile

(Get Free Report)

Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software. The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.

Further Reading

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.